Prospective evaluation of small molecule EGFR [epidermal growth factor receptor]-1 tyrosine kinase inhibition as a first-line treatment in patients with advanced non-small cell lung cancer (NSCLC) harbouring a mutant EGFR gene
Latest Information Update: 10 Nov 2021
At a glance
- Drugs Erlotinib (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 05 Dec 2006 New trial record.